Arca
Skip to content

SCN5A: Sodium channel protein type 5 subunit alpha

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes.

  • Drugs that act on it: 7
  • With a US drug page: 3
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DibucaineApprovedSodium channel protein type V alpha subunit blockerBlocker—
FlecainideApprovedSodium channel protein type V alpha subunit blockerBlockerBoxed warning
RanolazineApprovedSodium channel protein type V alpha subunit blockerBlocker—
AZD1305—Sodium channel protein type V alpha subunit blockerBlocker—
AZD7009—Sodium channel protein type V alpha subunit blockerBlocker—
Prenylamine—Sodium channel protein type V alpha subunit blockerBlockerWithdrawn
Vernakalant—Sodium channel protein type V alpha subunit blockerBlocker—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Brugada syndrome 1
0.84
Long QT syndrome 3
0.84
Progressive familial heart block, type 1A
0.80
Atrial fibrillation, familial, 10
0.80
Brugada syndrome
0.80
Dilated cardiomyopathy 1E
0.79
Cardiac arrhythmia
0.79
Sick sinus syndrome 1
0.78
Sudden infant death syndrome
0.77
Bundle branch block
0.76
Ventricular fibrillation, paroxysmal familial, type 1
0.74

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
SCN5A

Drugs and mechanisms are from ChEMBL CHEMBL1980 (CC BY-SA 3.0). Gene name, function (UniProt Q14524, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.